Dihydro-5-azacytidine in malignant mesothelioma : A Phase II trial demonstrating activity accompanied by cardiac toxicity

✍ Scribed by Nicholas J. Vogelzang; James E. Herndon II; Constance Cirrincione; David C. Harmon; Karen H. Antman; Joseph M. Corson; Yasunosuke Suzuki; Marc L. Citron; Mark R. Green

• Book ID: 101230573
• Publisher: John Wiley and Sons
• Year: 1997
• Tongue: English
• Weight: 84 KB
• Volume: 79
• Category: Article
• ISSN: 0008-543X
• DOI: 10.1002/(sici)1097-0142(19970601)79:11<2237::aid-cncr23>3.0.co;2-w

✦ Synopsis

BACKGROUND.

Malignant mesothelioma is a disease that is refractory to chemo-